89 related articles for article (PubMed ID: 28387912)
41. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
42. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Han M; Xu W
Tumour Biol; 2017 Jul; 39(7):1010428317718404. PubMed ID: 28718375
[TBL] [Abstract][Full Text] [Related]
43. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
[TBL] [Abstract][Full Text] [Related]
44. PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells.
Wang L; Niu CH; Wu S; Wu HM; Ouyang F; He M; He SY
Oncol Rep; 2016 Jan; 35(1):488-96. PubMed ID: 26549570
[TBL] [Abstract][Full Text] [Related]
45. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
Wu J; Wan F; Sheng H; Shi G; Shen Y; Lin G; Dai B; Zhu Y; Ye D
J Cancer; 2017; 8(5):852-860. PubMed ID: 28382148
[TBL] [Abstract][Full Text] [Related]
46. Clinical relevance of cytoskeleton associated proteins for ovarian cancer.
Schiewek J; Schumacher U; Lange T; Joosse SA; Wikman H; Pantel K; Mikhaylova M; Kneussel M; Linder S; Schmalfeldt B; Oliveira-Ferrer L; Windhorst S
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2195-2205. PubMed ID: 30094535
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
48. Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.
Sung PL; Jan YH; Lin SC; Huang CC; Lin H; Wen KC; Chao KC; Lai CR; Wang PH; Chuang CM; Wu HH; Twu NF; Yen MS; Hsiao M; Huang CY
Oncotarget; 2016 Jan; 7(4):4036-47. PubMed ID: 26716408
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma.
Siamakpour-Reihani S; Owzar K; Jiang C; Turner T; Deng Y; Bean SM; Horton JK; Berchuck A; Marks JR; Dewhirst MW; Alvarez Secord A
Gynecol Oncol; 2015 Oct; 139(1):23-9. PubMed ID: 26260910
[TBL] [Abstract][Full Text] [Related]
50. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients.
Proppe L; Jagomast T; Beume S; Klapper L; Gitas G; Köster F; Perner S; Rody A; Ribbat-Idel J; Hanker LC
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7155-7164. PubMed ID: 36884115
[TBL] [Abstract][Full Text] [Related]
53. Elevated expression of Tweety homologue 3 predicts poor clinical outcomes in ovarian cancer.
Zhou J; Xu Y; Chen X; Chen F; Zhang J; Zhu X
J Cancer; 2021; 12(23):7147-7157. PubMed ID: 34729116
[No Abstract] [Full Text] [Related]
54. Expression of ACAP1 Is Associated with Tumor Immune Infiltration and Clinical Outcome of Ovarian Cancer.
Zhang J; Zhang Q; Zhang J; Wang Q
DNA Cell Biol; 2020 Sep; 39(9):1545-1557. PubMed ID: 32456571
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer.
Jiang W; Chetry M; Pan S; Wang L; Zhu X
J Cancer; 2021; 12(9):2654-2664. PubMed ID: 33854625
[TBL] [Abstract][Full Text] [Related]
56. [Expression and significance of WFDC2 in ovarian cancer based on multiple gene databases].
Lu J; Yang Y; Yan K; Deng Z; Zhang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):528-534. PubMed ID: 30236206
[TBL] [Abstract][Full Text] [Related]
57. [The role of nuclear receptor transcription factor NR2F6 in tumor].
Huang L; Liu J; Zhu Y; Zhou Q; Xiao B; Sun Z; Li L
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2595-2602. PubMed ID: 34472280
[TBL] [Abstract][Full Text] [Related]
58. High throughput screening for compounds to the orphan nuclear receptor NR2F6.
Smith E; Campbell S; Wilson AN; Shumate J; Baillargeon P; Scampavia L; Kamenecka TM; Spicer TP; Solt LA
SLAS Discov; 2022 Jun; 27(4):242-248. PubMed ID: 35331960
[TBL] [Abstract][Full Text] [Related]
59. In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients.
Kassuhn W; Cutillas PR; Kessler M; Sehouli J; Braicu EI; Blüthgen N; Kulbe H
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370765
[TBL] [Abstract][Full Text] [Related]
60. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
